| Original document(8 pages) 中文版 |
The present invention belongs to the field of medicine technology, relates to compound antibiotic medicine capable of inhibiting bacteria produced beta-lactamase, and is especially compound antibiotic azlocillin/clavulanate medicine. The compound antibiotic azlocillin/clavulanate medicine is compounded with azlocillin and clavulanate in the weight ratio of 1-20 as the active components. Azlocillin and clavulanate in the compound medicine has obvious synergistic effect, and the compound medicine can inhibit the activity of beta-lactamase and protect azlocillin against the destruction of bacteria produced beta-lactamase, is favorable to the antibiotic effect of azlocillin in strengthen antibiotic activity, widened antibiotic spectrum, less resistance and raised clinical treating effect. |
Application Number
申请号 |
200510042209 |
Application Date
申请日 |
2005.03.21 |
| Title 名称 |
Azlocillin/clavulanic acid antibacterial composition
|
Publication Number
公开号 |
1836660 |
Publication Date
公开日 |
2006.09.27 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
A61K31/431,A61P31/04,A61K31/424 |
Applicant(s) Name
申请人 |
Shandong Reyoung Pharmaceutical Limitied Company |
| Address 地址 |
256100 |
| Inventor(s) Name 发明人 |
Zhao Yushan, He Maoqun, Ren Zhengwei, Li Guang, Wang Ziwei |
| Attorney & Agent 代理人 |
ma dunrong |
|
|